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Essay
I
n this Essay, we offer reﬂections 
based on our previously published 
ethnographic study of physician 
and patient responses to life-
extending cardiac procedures that 
are increasingly performed on ever 
older individuals in the United States 
[1]. In that study, we examined how 
providers and patients considered 
advanced age in their decision-making 
about various treatments (angioplasty, 
stents, bypass surgery, and implantable 
cardioverter deﬁbrillators), using 
in-depth interviews with physicians 
from internal medicine and cardiac 
subspecialties, cardiac patients aged 
72–86, and their family members. The 
project received institutional review 
board approval from the University 
of California, San Francisco, and all 
interviewees gave informed consent 
prior to participation. 
Despite evidence indicating that 
elderly patients tend to receive 
more conservative cardiac treatment 
than may be medically indicated 
[2,3], clinicians, patients, and family 
members in our study all perceived a 
nearly inescapable obligation to pursue 
cardiac interventions. We summarize 
here our ﬁndings on the socio-medical 
sources of this treatment imperative, 
and its impacts on physicians’ 
and patients’ encounters with life-
prolonging cardiac procedures. Based 
on our study ﬁndings, we then offer 
several recommendations regarding 
patient–provider communication that 
seek to improve the experiences of 
elderly patients, and perhaps those of 
physicians as well.
The Treatment Imperative as a 
Clinical–Ethical Obligation
Underlying the treatment imperative 
are at least three changes in the 
socio-clinical landscape of cardiac 
intervention in the US. First, the 
social meaning of cardiac treatments 
has shifted, from aggressive, high-risk 
interventions to increasingly routine, 
standard procedures. As less invasive 
procedures are used safely, effectively, 
and with greater frequency among 
older Americans to enhance well-being 
and longevity [4–6], both consumer 
demand for and the ethical pressure 
to offer them have increased. Second, 
norms of “old age” have shifted in 
US society and in clinical medicine 
[7,8]. Physicians described changing 
deﬁnitions of “how old is ‘old.’” In 
addition, physicians viewed old age 
not as a time of inevitable decline and 
death but as one of preventable morbidity 
and mortality, when clinicians must 
“look forward for” and “treat for 
risk.” Third, the framing of medical 
choices for elderly Americans and their 
physicians is shaped by the Medicare 
system, in which reimbursement is tied 
to procedures performed. 
These three developments in 
cardiac medicine—reﬂective of 
wider changes throughout clinical 
medicine—produced an experience 
among the physicians we interviewed 
of an almost inexorable momentum 
towards treatment. One characterized 
the successive and escalating cardiac 
interventions often undertaken for very 
elderly people as a “speeding train.” 
Another called it an “extravaganza of 
cardiology” and a “technology parade,” 
in which a stream of cardiac specialists 
each performs a procedure that is 
medically indicated but also facilitated, 
in part, by those that preceded it. 
Yet even while clinicians experienced 
this compulsion to treat, they also 
afﬁrmed the need to consider the 
Late-Life Cardiac Interventions 
and the Treatment Imperative
Janet K. Shim*, Ann J. Russ, Sharon R. Kaufman
Funding: The study upon which this article is based 
was funded by the National Institute on Aging under 
grant AG20962 (to SRK, principal investigator). 
The funding source had no role in study design; 
collection, analysis, and interpretation of data; 
writing of the paper; or the decision to submit it for 
publication.
Competing Interests: The authors have declared 
that no competing interests exist.
Citation: Shim JK, Russ AJ, Kaufman SR (2008) 
Late-life cardiac interventions and the treatment 
imperative. PLoS Med 5(3): e7. doi:10.1371/journal.
pmed.0050007
Copyright: © 2008 Shim et al. This is an open-access 
article distributed under the terms of the Creative 
Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in 
any medium, provided the original author and source 
are credited.
Janet K. Shim is with the Department of Social and 
Behavioral Sciences, University of California San 
Francisco, San Francisco, California, United States of 
America. Ann J. Russ is with the Center for the Study 
and Prevention of Suicide, University of Rochester 
Medical Center, Rochester, New York, United States 
of America. Sharon R. Kaufman is with the Institute 
for Health and Aging, University of California San 
Francisco, San Francisco, California, United States of 
America.
* To whom correspondence should be addressed. 
E-mail: Janet.Shim@ucsf.edu
The Essay section contains opinion pieces on topics 
of broad interest to a general medical audience. 
Summary Points
u The “treatment imperative” refers to 
the almost inexorable momentum 
towards intervention that is 
experienced by physicians, patients, 
and family members alike.
u Even in the presence of reservations 
about the appropriateness of 
continued treatment, decisions 
regarding cardiac treatment in late life 
are often scripted to favor intervention.
u This technological ethic is driven by 
rising expectations for vitality and 
longevity, the growing availability of 
options for intervention, changing 
norms of old age, and the stark 
urgency presented by cardiac risks 
that are reducible through increasingly 
reliable procedures. 
u The treatment imperative has become 
a standard of ethical clinical practice, 
and together with social changes and 
Medicare policies, contributes to an 
“extravaganza of cardiology” at ever 
older ages.
u However, we argue that clinicians can 
bring questions of ethics, quality of life, 
and the limits of cardiac intervention 
into better expression in their 
interactions with their patients, and we 
offer suggestions for how to do so.PLoS Medicine  |  www.plosmedicine.org 0345 March 2008  |  Volume 5  |  Issue 3  |  e7
ethical appropriateness of a cardiac 
“full-court press” [9]. An interventional 
cardiologist cautioned, “I can get 
the patient through a lot, but you’ve 
got to think, what’s your end-point?” 
A cardiac surgeon talked about the 
need to question whether meaningful 
life prolongation can be achieved 
with those patients hard-pressed 
to withstand the “march” through 
cardiology, catheterization lab, 
operating room, intensive care unit, 
and recovery facility. 
Yet clinicians conﬁded that they 
found it difﬁcult to know how and 
when to pose such questions to their 
patients or to voice the doubts that 
underlie them. They attributed this 
difﬁculty, ﬁrst, to their inability to 
prognosticate reliably which patients 
will experience positive, negative, or 
unchanged outcomes, particularly 
among the elderly [10]. As a result, 
practitioners said they based decisions 
not on whether patients would be well-
served in the long term by a speciﬁc 
treatment, but largely on whether they 
were simply eligible for a procedure. 
Second, clinicians perceived that 
their difﬁculty with prognostication 
in turn imposed an ethical injunction 
against raising questions about the 
appropriateness of pursuing therapies. 
Physicians believed that expressing 
any such doubts in the absence of 
reliable clinical predictions would be 
morally equivalent to substituting their 
own treatment preferences and values 
regarding quality of life for those of their 
patients [11,12]. As a cardiac surgeon 
put it, “You would never want to see a 
physician if you thought that for one 
second he was weighing whether or not 
your social worth and potential longevity 
are such that we should put this amount 
of resource into making you well.” 
Third, our physician respondents 
reported avoiding discussions about 
meaningful life extension because of a 
phenomenon we called “technological 
incrementalism”: once treatment of 
any kind is initiated, each successive 
procedure is relatively easy to 
justify because it is seen to be only 
incrementally more or less risky than 
the previous one [1]. Such serial, 
piece-meal intervention is “hard to 
grind to a halt,” as one doctor put it, 
because there are no clear points in 
the treatment trajectory when it seems 
clinically or morally acceptable to refuse 
to move to that next step. The need to 
address the clinical exigencies of the 
moment mostly trumped reﬂection 
about the long-term aims of cumulative 
therapies and the consideration of 
comfort or palliative care as either 
an alternative or supplement to life-
prolonging interventions.
Clinicians instead reported feeling 
duty-bound to “err on the side of doing 
interventions,” “cover the bases,” and 
“give the patient the beneﬁt of the 
doubt.” Clinicians viewed this as the only 
appropriate way to navigate through 
the complex thicket of prognostic 
ambiguity, personal judgments about 
quality of life, and the actual and 
perceived promise of medicine. As a 
result, the treatment imperative came 
to embody for physicians both a clinical 
standard of care as well as the deﬁnition 
of ethical responsibility. 
Unstated Options: The 
Consequences for Patients
Patients and families experienced the 
treatment imperative as well. Their 
desire to maximize quality of life and 
longevity, together with their sense of 
familial obligation, made it extremely 
difﬁcult to forego medical options. But, 
in addition, patients rarely recalled any 
communication regarding potentially 
negative treatment outcomes, other 
than during informed consent 
procedures which many viewed as 
mandatory, cursory, and overly general. 
Most indicated that they were not 
offered the option of no treatment. 
One woman related that her physician 
told her baldly, “‘It’s not a choice 
of whether you want to go through 
[treatment] or not if you want to live.’ 
When you’re faced with that kind of 
a ‘choice,’” this patient said, “your 
decision is made for you.”
We heard from patients that when 
their physicians did not explicitly 
present the option of no treatment, 
patients assumed that their doctors 
believed a positive outcome to be so 
likely that nonintervention was out of 
the question. The lack of any kind of 
countervailing or meaningful discussion 
regarding possible risks, negative 
outcomes, and death from the patients’ 
perspectives led to their unqualiﬁed 
conﬁdence in life-prolonging 
interventions [13]. Older individuals’ 
expectations about post-procedure life 
therefore were shaped as much by what 
was left unsaid as by what was said. 
Consequently, patients were often 
shocked and demoralized when 
treatment failed to help. While 
physicians understand unchanged 
or negative outcomes as being well 
within the range of the possible, such 
results led patients to question the 
value of their existence, and eroded 
the trust they placed in medicine and 
their doctors. “I’m utterly useless, a 
vegetable … I don’t know what to do 
with myself,” sobbed one such patient. 
Another asked, contemplating her 
bleak future, “Do I have to continue 
this way? I would rather [my life] 
ended, but I’m not in a mood to 
commit suicide.”
Reﬂections and Recommendations
Medical intervention in late life can be 
characterized by a tension between the 
desire for prolonged life and a wish for 
a digniﬁed end. Conventional framings 
of this debate have usually resolved this 
tension, at least in the hypothetical, 
by invoking patient “autonomy” and 
shared decision-making [14–16]. By 
facilitating these values, it is suggested, 
patients will be able to decide for 
themselves whether to prolong life or 
allow death, and physicians will be able 
to adjust their recommendations to 
reﬂect patients’ desires. But the ideal of 
patient choice and the discernment of 
patients’ authentic values are extremely 
elusive [17,18]. 
The developments we describe 
have permeated the social fabric of 
our society and the organization and 
culture of medicine. And they have 
left us in a quandary. Physicians, 
patients, families, and the public may 
feel uneasy about a full-court press 
approach to clinical intervention at 
ever older ages. Yet it is difﬁcult to 
imagine an alternative response to the 
treatment imperative. It feels naïve or 
overly reactionary to say “no” to the 
medical options that already exist, or 
to slow down or stop the technology 
parade, even if at times it feels more 
like a runaway train. Nor is it possible 
to imagine a future without expanding 
clinical choices. Our growing ability to 
extend life has become part of how we 
envision life itself and the malleability 
of our bodies and futures. 
Norms of “old age” have 
shifted in US society and 
in clinical medicine.PLoS Medicine  |  www.plosmedicine.org 0346 March 2008  |  Volume 5  |  Issue 3  |  e7
Our ethnographic evidence indicates 
that questions about death, quality 
of life, and the limits of intervention 
are often not expressed in patient–
physician conversations about cardiac 
procedures. Given the structural and 
ethical pressures to offer and accept 
treatments, what can physicians do to 
better guide their older patients in 
making therapeutic decisions? Based 
on our ﬁndings, we offer two modest 
recommendations.
First, clinicians can make the option 
of accepting no intervention aimed 
solely at extending life an explicit one. 
Such an articulation might be the very 
entrée some patients, families, and 
physicians need in our procedure-
driven system to bring their concerns 
regarding the appropriateness of 
life prolongation above ground. In 
so doing, physicians may feel more 
comfortable discussing symptom 
control and comfort measures, and 
patients and families may better grasp 
whatever added risks their health status 
and advanced age might pose—even if, 
in the end, they still ﬁnd it impossible 
to forego treatment. 
Second, clinicians can communicate 
more explicitly the full range of 
possible outcomes, and further, can 
attempt to describe the probable 
outcomes for that individual patient. 
Nicholas Christakis has written 
eloquently about the myriad reasons 
why physicians are “reluctant 
prophets,” and he offers numerous 
ideas for how doctors might more 
accurately formulate and communicate 
prognoses [10]. Our study suggests 
that patients tend to assume the 
positive when physicians do not state 
(in a manner that patients are likely 
to hear) the possibilities for negative 
results. Older individuals subsequently 
are demoralized by the unanticipated 
outcomes of no change or worsening 
health, which undermines their trust 
in medicine and their doctors, upon 
whom they must continue to depend.
We are well aware of the obstacles 
that stand in the way of making these 
kinds of improvements [19]. For 
example, it may be that physicians 
are sharing information that patients 
retrospectively believe would have been 
helpful, but patients do not apprehend 
it at the time. Sensitive conversations 
about values and visions for life near 
its end, which are already difﬁcult to 
initiate and navigate, may be impossible 
to carry out in a meaningful way when 
time is short, as it is in most clinical 
settings today. Some, perhaps many, 
patients may abjure the responsibility 
of making medical decisions and 
so do not wish to participate in 
communication regarding them. Or 
it may be that no matter how much 
advance information patients are 
given, shock and disappointment are 
unavoidable when treatment fails to 
help. Finally, we must acknowledge 
that a health care and reimbursement 
system predicated on intervention can 
thwart the effects of any communicative 
efforts by individual physicians. Given 
human hope and the desire to live, 
it is difﬁcult to expect patients and 
clinicians to sometimes say “no” when 
they are immersed in an organizational 
context and culture of hope that mostly 
says “yes.” 
Despite such obstacles, we do not 
believe that any of the clinicians we 
spoke with, nor the larger medical 
community, would concede that the 
treatment imperative is inevitable, 
or that the mere existence of an 
intervention determines our use of 
it. However individual patients and 
doctors respond to the question of 
whether or not to intervene, it must 
remain just that: a question to be posed 
and a decision to be made, rather 
than a routine, normalized course of 
action, against which all other paths 
become increasingly inconceivable 
and unavailable. In an era in which we 
desire and believe in patient choice 
as an ideal—even if we struggle with 
its actual consequences for clinical 
practice and human experience—it 
would be an ultimate irony if alternative 
choices to the treatment imperative 
were increasingly narrowed.  
Acknowledgments
We are indebted to the health professionals, 
patients, and family members who took the 
time to speak with us in 2003–2005.
Author contributions. The data reported 
here are part of a larger collaboration 
among all three authors, all of whom have 
contributed substantially to the design of 
this larger project, and to its data collection, 
analysis, and interpretation. The ﬁrst author, 
Janet K. Shim, collected the data discussed 
in this Essay and took the lead in writing 
the preliminary draft. All three authors 
contributed to subsequent critical revisions 
for intellectual content, and have approved 
the ﬁnal version of this manuscript. 
References
1. Shim JK, Russ AJ, Kaufman SR (2006) Risk, 
life extension, and the pursuit of medical 
possibility. Sociol Health Illn 28: 479-502.
2. Alexander KP, Galanos AN, Jollis JG, Stafford 
JA, Peterson ED (2001) Post-myocardial 
infarction risk stratiﬁcation in elderly patients. 
Am Heart J 142: 37-42.
3. Alexander KP, Roe MT, Chen AY, Lytle 
BL, Pollack J, et al. (2005) Evolution in 
cardiovascular care for elderly patients with 
non-ST-segment elevation acute coronary 
syndromes: Results from the CRUSADE 
National Quality Improvement Initiative. J Am 
Coll Cardiol 46: 1479-1487.
4. Katz NM, Gersh BJ, Cox JL (1998) Changing 
practice of coronary bypass surgery and its 
impact on early risk and long-term survival. 
Curr Opin Cardiol 13: 465-475.
5. Maisel WH (2006) Pacemaker and ICD 
generator reliability: Meta-analysis of device 
registries. JAMA 295: 1929-1934.
6. Peterson ED, Alexander KP, Malenka DJ, 
Hannan EL, O’Conner GT, et al. (2004) 
Multicenter experience in revascularization of 
very elderly patients. Am Heart J 148: 486-492.
7. Anderson HV, Bach RG (2005) The elderly 
are not so old anymore. J Am Coll Cardiol 46: 
1488-1489.
8. Kaufman SR, Shim JK, Russ AJ (2004) 
Revisiting the biomedicalization of aging: 
Clinical trends and ethical challenges. 
Gerontologist 44: 731-738.
9. Kolata G (2004 March 21) New studies 
question value of opening arteries. The New 
York Times. Available: http://www.nytimes.
com/2004/03/21/health/21HEAR.html.
Accessed 30 January 2008.
10. Christakis NA (1999) Death foretold: Prophecy 
and prognosis in medical care. Chicago: 
University of Chicago Press. 328 p.
11. Schneiderman LJ, Kaplan RM, Rosenberg E, 
Teetzel H, Pearlman RA (1997) Do physicians’ 
own preferences for life-sustaining treatment 
inﬂuence their perceptions of patients’ 
preferences? A second look. Camb Q Healthc 
Ethics 6: 131-137.
12. Uhlmann RF, Pearlman RA (1991) Perceived 
quality of life and preferences for life-
sustaining treatment in older adults. Arch 
Intern Med 151: 495-497.
13. Weeks J, Cook E, O’Day S, Peterson L, Wenger 
N, et al. (1998) Relationship between cancer 
patients’ predictions of prognosis and their 
treatment preferences. JAMA 279: 1709-1714.
14. Crane MK, Wittink M, Doukas DJ (2005) 
Respecting end-of-life treatment preferences. 
Am Fam Physician 72: 1263-1268.
15. Meier DE, Morrison RS (2002) Autonomy 
reconsidered. N Engl J Med 346: 1087-1089.
16. Thompson BT, Cox PN, Antonelli M, Carlet 
JM, Cassell J, et al. (2003) Challenges in end-
of-life care in the ICU: Statement of the 5th 
International Consensus Conference in Critical 
Care: Brussels, Belgium, April 2003: Executive 
summary. Crit Care Med 32: 1781-1784.
17. Drought TS, Koenig BA (2002) “Choice” in 
end-of-life decision making: Researching fact 
or ﬁction? Gerontologist 42: 114-128.
18. Schneider CE (2002) The practice of autonomy 
and the practice of bioethics. J Clin Ethics 13: 72-77.
19. Lynn J, Arkes HR, Stevens M, Cohn F, Koenig 
B, et al. (2000) Rethinking fundamental 
assumptions: SUPPORT’s implications for 
future reform. J Am Geriatr Soc 48: S214-S221.
Clinicians can 
communicate more 
explicitly the full range 
of possible outcomes.